Literature DB >> 2989533

Messenger RNAs from the transforming region of bovine papilloma virus type I.

A Stenlund, J Zabielski, H Ahola, J Moreno-Lopez, U Pettersson.   

Abstract

Messenger RNAs present in C127 mouse cells transformed by bovine papilloma virus type 1 (BPV-1) were studied by the S1 nuclease protection technique, Northern blotting, and electron microscopic heteroduplex analysis. The results revealed at least five classes of spliced mRNAs which we designate types 1 to 5. They had a common poly(A) addition site located at co-ordinate 53 and all mRNAs, except the type 3 mRNAs, contained an exon located between co-ordinates 41 and 53. In the type 1 mRNAs this exon was connected to a very short leader sequence located around co-ordinate 31. The type 2 mRNAs contained 220 to 400-nucleotide long leaders which were located approximately 1.5 X 10(3) base-pairs further upstream. Two different subclasses of type 2 molecules (2A and 2B) were identified and these had slightly different leaders. The type 4 mRNAs contained a bipartite leader, whereas the type 5 mRNAs carried an approximately 900-nucleotide long leader. The type 3 mRNAs consisted of a main exon located between co-ordinates 32 and 53, linked to the same leader as is present in the type 2A mRNAs. A cap site which presumably is utilized by the type 2A, type 3, type 4 and type 5 mRNAs was mapped at nucleotide 89 in the BPV-1 sequence. A putative cap site for the type 1 mRNAs was mapped at co-ordinate 31.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989533     DOI: 10.1016/0022-2836(85)90240-2

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  70 in total

1.  Reindeer papillomavirus transforming properties correlate with a highly conserved E5 region.

Authors:  J Moreno-Lopez; H Ahola; A Eriksson; P Bergman; U Pettersson
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Mutational analysis of the 3' open reading frames and the splice junction at nucleotide 3225 of bovine papillomavirus type 1.

Authors:  P L Hermonat; P M Howley
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Multiple cis-active elements in the long control region of bovine papillomavirus type 1 (BPV-1).

Authors:  S M Harrison; K L Gearing; S Y Kim; A J Kingsman; S M Kingsman
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

4.  Messenger RNAs from the E1 region of bovine papillomavirus type 1 detected in virus-infected bovine cells.

Authors:  S Burnett; J Moreno-Lopez; U Pettersson
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

5.  Biologic properties and nucleotide sequence analysis of human papillomavirus type 51.

Authors:  O Lungu; C P Crum; S Silverstein
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor.

Authors:  S B Vande Pol; P M Howley
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts.

Authors:  D A Palermo-Dilts; T R Broker; L T Chow
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity.

Authors:  J T Schiller; E Kleiner; E J Androphy; D R Lowy; H Pfister
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

9.  Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions.

Authors:  P A Furth; W T Choe; J H Rex; J C Byrne; C C Baker
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

10.  Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P2443 promoter.

Authors:  B A Spalholz; S B Vande Pol; P M Howley
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.